Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03880123
Title Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Matthew Ingham
Age Groups: child | adult | senior
Covered Countries USA

No variant requirements are available.